Cost of innovation in the pharmaceutical industry
- 1 July 1991
- journal article
- Published by Elsevier in Journal of Health Economics
- Vol. 10 (2) , 107-142
- https://doi.org/10.1016/0167-6296(91)90001-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A New Look at the Returns and Risks to Pharmaceutical R&DManagement Science, 1990
- New drug development in the United States, 1963 through 1984Clinical Pharmacology & Therapeutics, 1988
- Price Indexes for R and D Inputs, 1969–1983Management Science, 1987
- A closer look at the returns and risks of pharmaceutical R&DJournal of Health Economics, 1986
- Success rates in the United States drug development systemClinical Pharmacology & Therapeutics, 1984
- A sensitivity analysis of expected profitability of pharmaceutical research and developmentManagerial and Decision Economics, 1982
- Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical IndustryThe Journal of Law and Economics, 1978
- Impact of Regulations on Industrial R&D: FDA Regulations and Their Influence on Future R&DResearch Management, 1974
- Research and Development Costs and Returns: The U.S. Pharmaceutical IndustryJournal of Political Economy, 1972
- Development Cost: Determinants and OverrunsThe Journal of Business, 1972